Seth B. Krantz

1.8k total citations
44 papers, 1.2k citations indexed

About

Seth B. Krantz is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Seth B. Krantz has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Seth B. Krantz's work include Pancreatic and Hepatic Oncology Research (8 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Seth B. Krantz is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Lung Cancer Diagnosis and Treatment (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Seth B. Krantz collaborates with scholars based in United States, United Kingdom and Germany. Seth B. Krantz's co-authors include Hidayatullah G. Munshi, Surabhi Dangi‐Garimella, Mario A. Shields, David J. Bentrem, David J. Bentrem, Eric C. Cheon, Paul J. Grippo, Matthew J. Strouch, Khashayarsha Khazaie and Michael J. Heiferman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Seth B. Krantz

42 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Seth B. Krantz United States 17 583 344 317 268 245 44 1.2k
Terufumi Kubo Japan 20 504 0.9× 477 1.4× 437 1.4× 243 0.9× 151 0.6× 92 1.3k
Jeena Joseph India 17 864 1.5× 722 2.1× 285 0.9× 308 1.1× 155 0.6× 41 1.8k
Kazuo Yasumoto Japan 15 616 1.1× 436 1.3× 408 1.3× 234 0.9× 112 0.5× 39 1.2k
Lai‐ping Zhong China 24 461 0.8× 667 1.9× 195 0.6× 172 0.6× 414 1.7× 96 1.7k
Zhi Zhu China 23 479 0.8× 634 1.8× 203 0.6× 489 1.8× 340 1.4× 88 1.5k
Henning Wege Germany 20 526 0.9× 660 1.9× 219 0.7× 224 0.8× 431 1.8× 64 1.8k
Dominik Horn Germany 17 398 0.7× 504 1.5× 165 0.5× 129 0.5× 240 1.0× 62 1.1k
M Miyamoto Japan 20 713 1.2× 481 1.4× 496 1.6× 216 0.8× 406 1.7× 41 1.6k
Salomé González‐Reyes Spain 17 322 0.6× 252 0.7× 319 1.0× 157 0.6× 170 0.7× 34 974
Xueli Liu China 18 377 0.6× 514 1.5× 172 0.5× 477 1.8× 237 1.0× 45 1.3k

Countries citing papers authored by Seth B. Krantz

Since Specialization
Citations

This map shows the geographic impact of Seth B. Krantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seth B. Krantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seth B. Krantz more than expected).

Fields of papers citing papers by Seth B. Krantz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seth B. Krantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seth B. Krantz. The network helps show where Seth B. Krantz may publish in the future.

Co-authorship network of co-authors of Seth B. Krantz

This figure shows the co-authorship network connecting the top 25 collaborators of Seth B. Krantz. A scholar is included among the top collaborators of Seth B. Krantz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seth B. Krantz. Seth B. Krantz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tafur, Alfonso, Zhuqing Shi, Huy Tran, et al.. (2025). Polygenic risk score to define risk of cancer-associated thrombosis among patients with lung cancer in a population-based study. Lung Cancer. 207. 108712–108712.
2.
Pai, Shweta, Ashok Muniappan, Aaron D. Friedman, et al.. (2024). 992O Pembrolizumab for HPV-associated recurrent respiratory papillomatosis. Annals of Oncology. 35. S676–S676. 2 indexed citations
3.
Martínez‐López, Beatriz, María J. Clavijo, Carlos González‐Crespo, et al.. (2023). Infection prediction in swine populations with machine learning. Scientific Reports. 13(1). 17738–17738. 2 indexed citations
4.
Krantz, Seth B., Kristine Kuchta, Thomas A. Hensing, et al.. (2022). Germline mutations in high penetrance genes are associated with worse clinical outcomes in patients with non–small cell lung cancer. JTCVS Open. 12. 399–409. 2 indexed citations
5.
Mitzman, Brian, Thomas K. Varghese, Kristine Kuchta, & Seth B. Krantz. (2022). National guideline concordance and outcomes for pathologic N2 disease in non-small cell lung cancer. Journal of Thoracic Disease. 14(5). 1360–1373. 2 indexed citations
6.
Krantz, Seth B., John A. Howington, Douglas E. Wood, et al.. (2018). Invasive Mediastinal Staging for Lung Cancer by The Society of Thoracic Surgeons Database Participants. The Annals of Thoracic Surgery. 106(4). 1055–1062. 23 indexed citations
7.
Ajmani, Gaurav S., Chi‐Hsiung Wang, Ki Wan Kim, John A. Howington, & Seth B. Krantz. (2018). Surgical quality of wedge resection affects overall survival in patients with early stage non–small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery. 156(1). 380–391.e2. 28 indexed citations
8.
Krantz, Seth B., Brian Mitzman, Waseem Lutfi, et al.. (2018). Neoadjuvant Chemoradiation Shows No Survival Advantage to Chemotherapy Alone in Stage IIIA Patients. The Annals of Thoracic Surgery. 105(4). 1008–1016. 19 indexed citations
9.
Mitzman, Brian, et al.. (2017). Minimally Invasive Esophagectomy Provides Equivalent Survival to Open Esophagectomy: An Analysis of the National Cancer Database. Seminars in Thoracic and Cardiovascular Surgery. 29(2). 244–253. 36 indexed citations
10.
Grippo, Paul J., David J. Bentrem, Laleh G. Melstrom, et al.. (2012). Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice. Gut. 61(10). 1454–1464. 63 indexed citations
11.
Cheon, Eric C., Khashayarsha Khazaie, Mohammad W. Khan, et al.. (2011). Mast Cell 5-Lipoxygenase Activity Promotes Intestinal Polyposis in APCΔ468 Mice. Cancer Research. 71(5). 1627–1636. 73 indexed citations
12.
Krantz, Seth B., Mario A. Shields, Surabhi Dangi‐Garimella, et al.. (2011). MT1-MMP Cooperates with KrasG12D to Promote Pancreatic Fibrosis through Increased TGF-β Signaling. Molecular Cancer Research. 9(10). 1294–1304. 52 indexed citations
13.
Shields, Mario A., Surabhi Dangi‐Garimella, Seth B. Krantz, David J. Bentrem, & Hidayatullah G. Munshi. (2011). Pancreatic Cancer Cells Respond to Type I Collagen by Inducing Snail Expression to Promote Membrane Type 1 Matrix Metalloproteinase-dependent Collagen Invasion. Journal of Biological Chemistry. 286(12). 10495–10504. 100 indexed citations
14.
Cheon, Eric C., Matthew J. Strouch, Seth B. Krantz, Michael J. Heiferman, & David J. Bentrem. (2011). Genetic Deletion of 5-Lipoxygenase Increases Tumor-Infiltrating Macrophages in ApcΔ468 Mice. Journal of Gastrointestinal Surgery. 16(2). 389–393. 7 indexed citations
15.
Krantz, Seth B., Mario A. Shields, Surabhi Dangi‐Garimella, Hidayatullah G. Munshi, & David J. Bentrem. (2011). Contribution of Epithelial-to-Mesenchymal Transition and Cancer Stem Cells to Pancreatic Cancer Progression. Journal of Surgical Research. 173(1). 105–112. 72 indexed citations
16.
Strouch, Matthew J., Eric C. Cheon, Mohammad R. Salabat, et al.. (2010). Crosstalk between Mast Cells and Pancreatic Cancer Cells Contributes to Pancreatic Tumor Progression. Clinical Cancer Research. 16(8). 2257–2265. 149 indexed citations
17.
Dangi‐Garimella, Surabhi, Seth B. Krantz, Morgan R. Barron, et al.. (2010). Three-Dimensional Collagen I Promotes Gemcitabine Resistance in Pancreatic Cancer through MT1-MMP–Mediated Expression of HMGA2. Cancer Research. 71(3). 1019–1028. 142 indexed citations
18.
Cheon, Eric C., William Small, Matthew J. Strouch, et al.. (2010). The effects of bevacizumab on postoperative complications in patients undergoing colorectal and pancreatic cancer resection. Journal of Surgical Oncology. 102(5). 539–542. 7 indexed citations
19.
Krantz, Seth B., et al.. (2009). An evaluation of gender and racial disparity in the decision to treat surgically arterial disease. Journal of Vascular Surgery. 50(6). 1340–1347. 51 indexed citations
20.
Sener, Stephen, David J. Winchester, David P. Winchester, et al.. (2009). The effects of hormone replacement therapy on postmenopausal breast cancer biology and survival. The American Journal of Surgery. 197(3). 403–407. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026